HIK Hikma Pharmaceuticals Plc

TIDMHIK

RNS Number : 1152J

Hikma Pharmaceuticals Plc

11 August 2023

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Hikma Pharmaceuticals PLC - Executive Incentive Plan Option Exercise and Sale

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                           Susan Ringdal 
 2    Reason for the notification 
 a)   Position/status                PDMR 
 b)   Initial notification           Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                           Hikma Pharmaceuticals PLC 
 b)   LEI                            549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of                 Description: Ordinary shares of 10 pence each 
       the financial                  (Shares) 
       instrument, type               ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the                  Acquisition of Shares pursuant to the exercise 
       transaction                    of options granted at nil-cost under the 2014 
                                      Executive Incentive Plan 
 c)   Price(s) and                   Price(s): nil 
       volume(s)                      Volume(s): 25,012 
 d)   Aggregated information 
        *    Volume 
                                      25,012 
                                      nil 
        *    Price                    nil 
 
 
 
        *    Total 
 e)   Date of the transaction        10 August 2023 
 f)   Place of the                   Outside a trading venue 
       transaction 
4    Details of the transaction(s): section to be repeated for 
      (i) each type of instrument; (ii) each type of transaction; 
      (iii) each date; and (iv) each place where transactions have 
      been conducted 
a)   Description of                  Description: Ordinary shares of 10 pence each 
      the financial                   (Shares) 
      instrument, type                ID Code: GB00B0LCW083 
      of instrument 
      and identification 
      code 
b)   Nature of the                    Sale of Shares 
      transaction 
c)   Price(s) and                     Price(s): GBP22.03 
      volume(s) 
                                       Volume(s): 25,012 
d)          Aggregated information 
             - Volume 
                                      25,012 
                                      GBP22.03 
             - Price                  GBP551,208.96 
 
             - Total 
e)   Date of the transaction         10 August 2023 
f)   Place of the                    London Stock Exchange (XLON) 
      transaction 
 

Helen Middlemist, Deputy Company Secretary

+44 (0) 20 7399 2760

11 August 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBBGDIXSBDGXB

(END) Dow Jones Newswires

August 11, 2023 09:00 ET (13:00 GMT)

Hikma Pharmaceuticals (LSE:HIK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Hikma Pharmaceuticals (LSE:HIK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024